Document is current
Any future updates will be listed below
-
Authors
Siegel, Joshua S. https://orcid.org/0000-0002-5752-3641
Liston, Conor https://orcid.org/0000-0002-1639-5401
Nicol, Ginger E. https://orcid.org/0000-0001-5823-6129
Carhart-Harris, Robin L. https://orcid.org/0000-0002-6062-7150
Bogenschutz, Michael P. https://orcid.org/0000-0003-4530-3470
- License Information
-
More Information
Article History
Received: 18 August 2025
Accepted: 17 December 2025
First Online: 6 February 2026
Competing interests
: J.S.S. is a consultant for Otsuka and Janssen and holds a provisional patent for the use of precision functional mapping for measuring target engagement by experimental therapeutics. C.L. has served as a scientific advisor to Delix Therapeutics and Brainify. G.E.N. has served as principal or co-investigator on studies funded by Alkermes, LB Pharmaceuticals, COMPASS Pathways, Usona Institute and Reunion Neuroscience. G.E.N. has served as a paid consultant for Carelon and Alkermes. R.L.C.-H. is a scientific advisor to TRYP therapeutics, MindSpace and Otsuka. M.P.B. has received research funding from Tilray Canada, Lykos Therapeutics, B.More, Ceruvia Life Sciences and Mind Medicine, serves on the Advisory Boards of Ajna Labs, Journey Colab and Bright Minds Biosciences, and provides consultation to Lilly USA and Otsuka Pharmaceutical Development & Commercialization.
